Hospital Universitario Son Espases-ko ikertzaileekin lankidetzan egindako argitalpenak (36)

2024

  1. Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 16-22

  2. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

2023

  1. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  2. Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 717-724

2022

  1. Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study

    Respiratory Research, Vol. 23, Núm. 1

  2. Respiratory symptoms and their determinants in the general Spanish population: changes over 20 years

    ERJ Open Research, Vol. 8, Núm. 4

  3. Spanish COPD Guidelines (GesEPOC) 2021 Update Diagnosis and Treatment of COPD Exacerbation Syndrome

    Archivos de Bronconeumologia, Vol. 58, Núm. 2, pp. 159-170

  4. Spanish COPD Guidelines (GesEPOC) 2021: Updated Pharmacological treatment of stable COPD

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 69-81

  5. [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care

    Archivos de Bronconeumologia, Vol. 58, Núm. 4, pp. T334-T344

2021

  1. COPD Clinical Control: predictors and long-term follow-up of the CHAIN cohort

    Respiratory research, Vol. 22, Núm. 1, pp. 36

  2. Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients With Global Initiative for Obstructive Lung Disease I COPD

    Chest, Vol. 160, Núm. 3, pp. 872-878

  3. Prevalence and Determinants of COPD in Spain: EPISCAN II

    Archivos de Bronconeumologia, Vol. 57, Núm. 1, pp. 61-69

  4. Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care

    Archivos de Bronconeumologia

  5. Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update

    Archivos de Bronconeumologia

2020

  1. A delphi consensus document on the use of single-inhaler fixed-dose triple therapies in copd patients

    International Journal of COPD, Vol. 15, pp. 1801-1811

  2. Mortality prediction in chronic obstructive pulmonary disease comparing the gold 2015 and gold 2019 staging: A pooled analysis of individual patient data

    ERJ Open Research, Vol. 6, Núm. 4, pp. 1-10

  3. Phenotypic characterisation of early copd: A prospective case–control study

    ERJ Open Research, Vol. 6, Núm. 4, pp. 1-13

2019

  1. 10 Years After EPISCAN: A New Study on the Prevalence of COPD in Spain —A Summary of the EPISCAN II Protocol

    Archivos de Bronconeumologia, Vol. 55, Núm. 1, pp. 38-47

2018

  1. Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort

    Chest, Vol. 154, Núm. 2, pp. 274-285

  2. Large-scale external validation and comparison of prognostic models: An application to chronic obstructive pulmonary disease

    BMC Medicine, Vol. 16, Núm. 1